Eli Lilly & Co. vs. Regeneron Pharmaceuticals Inc
Eli Lilly & Co. (LLY) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| LLY | REGN | |
|---|---|---|
| Market Cap | $1.28 trillion | $94.76 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | REGN | |
|---|---|---|
| Dividend Yield | 0.48% | 0.39% |
LLY leads on 1 of 1 dividend factors.
Risk & Sentiment
| LLY | REGN | |
|---|---|---|
| Short Interest | 1.29% | 1.82% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, REGN overview, REGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.